共 19 条
[1]
Patel H., Polanco-Echeverry G., Segditas S., Et al., Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous carcinoma, Int J Cancer, 121, pp. 2668-2673, (2007)
[2]
Glynne-Jones R., Nilsson P.J., Aschele C., Goh V., Et al., Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up, Ann of Oncol, pp. 1-11, (2014)
[3]
Epidermoid anal cancer: results from the UKCCR randomized trial of radiotherapy alone versus radiotherapy, 5- fluorouracil and mitomycin, Lancet, 348, pp. 1049-1054, (1996)
[4]
Bartelink H., Roelofsen F., Eschwege F., Et al., Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, J Clin Oncol, 15, pp. 2040-2049, (1997)
[5]
Bosset J.F., Roelofsen F., Morgan D.A.L., Et al., Shortened irradiation schedule, continous infusion of 5-fluorouracil and fractionation of mitomycin in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups, Eur J Cancer, 39, pp. 45-51, (2003)
[6]
Park J.H., Yoon S.H., Yu C.S., Kim J.H., Kim T.W., Kim J.C., Ramdomized phase 3 trial comparing preoperative and postoperative chemoradiotherapy with capecitabine for locally advanced rectal cancer, Cancer, 117, 16, (2011)
[7]
Hofheinz R.D., Wenz F., Post S., Matzdorff A., Laechelt S., Hartmann J.T., Et al., Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial, Lancet Oncol., 13, pp. 579-588, (2012)
[8]
Glynne- Jones R., Meadows H., National cancer research institute anal subgroup and colorectal clinical oncology group. EXTRA—a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin in anal cancer, Int J Radiation Oncol Biol Phys, 72, 1, pp. 119-126, (2008)
[9]
Deenen M.J., Dewit L., Boot H., Beijnen J.H., Schellens J.H.M., Cats A., Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study, Int J Radiation Oncol Biol Phys, 85, 5, pp. 201-207, (2013)
[10]
Thind G., Johal B., Follwell M., Kennecke H.F., Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma, Radiat Oncol., 9, (2014)